Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
295M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
44M
-
Shares change
-
-2.23M
-
Total reported value, excl. options
-
$203M
-
Value change
-
-$12.2M
-
Put/Call ratio
-
0.38
-
Number of buys
-
55
-
Number of sells
-
-54
-
Price
-
$4.63
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q3 2016
157 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q3 2016.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44M shares
of 295M outstanding shares and own 14.92% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS INC (6.98M shares), BAKER BROS. ADVISORS LP (4.06M shares), BlackRock Fund Advisors (2.87M shares), VANGUARD GROUP INC (2.73M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.5M shares), STATE STREET CORP (2.43M shares), BlackRock Institutional Trust Company, N.A. (1.85M shares), FMR LLC (1.7M shares), Cormorant Asset Management, LLC (1.4M shares), and Voya Investment Management LLC (1.36M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.